Literature DB >> 7665148

Transitional cell carcinoma of the bladder: low incidence of human papillomavirus DNA detected by the polymerase chain reaction and in situ hybridization.

A Lopez-Beltran1, E Muñoz.   

Abstract

Viral studies on mammalian urothelium have shown an association between the bovine papillomavirus and cancer of the bladder in cattle. However, the evidence for human papillomavirus (HPV) involvement in urinary bladder in man is less clear. The aim of this study was to investigate the association between HPV DNA and transitional cell carcinoma of the bladder, using the highly sensitive polymerase chain reaction (PCR) and non-isotopic DNA in situ hybridization of formalin-fixed paraffin-embedded tissues from 76 patients. An HPV type specific set of primers was localized on the E6-gene for HPV 16/18 DNA. The second and third set of primers were specific for HPV 6/11 DNA. A biotinylated DNA probe which recognizes HPV 6/11, 16/18, and 31/33/35 was used for in situ hybridization. Of the 76 cases investigated, PCR analysis showed positive signals in seven (9.2%) of cases--six for HPV 16 DNA, and one for HPV 16 DNA and HPV 6 DNA. Four (5.2%) were also reactive for HPV 16/18 DNA using in situ hybridization. Most transitional cell carcinomas (71.4%) associated with HPV DNA were of high pathological grade/stage. One case had koilocytosis. Our results suggest that HPV DNA in transitional cell carcinoma is probably a rare occurrence, although the finding on the high risk HPV 16 DNA may indicate a role for it in this tumour's aetiology.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665148     DOI: 10.1111/j.1365-2559.1995.tb00276.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  8 in total

Review 1.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

2.  Human papillomavirus infection and bladder cancer risk: a meta-analysis.

Authors:  Ni Li; Lin Yang; Yawei Zhang; Ping Zhao; Tongzhang Zheng; Min Dai
Journal:  J Infect Dis       Date:  2011-07-15       Impact factor: 5.226

3.  Human papillomavirus and schistosomiasis associated bladder cancer.

Authors:  K Cooper; Z Haffajee; L Taylor
Journal:  Mol Pathol       Date:  1997-06

4.  Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridisation.

Authors:  C De Gaetani; G Ferrari; E Righi; S Bettelli; M Migaldi; P Ferrari; G P Trentini
Journal:  J Clin Pathol       Date:  1999-02       Impact factor: 3.411

5.  Human papilloma virus and p53 expression in bladder cancer in Egypt: relationship to schistosomiasis and clinicopathologic factors.

Authors:  Thanaa El A Helal; Mona T Fadel; Naglaa K El-Sayed
Journal:  Pathol Oncol Res       Date:  2006-09-23       Impact factor: 3.201

6.  Role of human papillomavirus in the development of urothelial carcinoma.

Authors:  Dilek Yavuzer; Nimet Karadayi; Taflan Salepci; Huseyin Baloglu; Ahmet Bilici; Dilek Sakirahmet
Journal:  Med Oncol       Date:  2010-04-29       Impact factor: 3.064

7.  Prevalence of six types of human papillomavirus in inverted papilloma and papillary transitional cell carcinoma of the bladder: an evaluation by polymerase chain reaction.

Authors:  K W Chan; K Y Wong; G Srivastava
Journal:  J Clin Pathol       Date:  1997-12       Impact factor: 3.411

8.  Human papillomavirus DNA as a factor determining the survival of bladder cancer patients.

Authors:  A Lopez-Beltran; A L Escudero; L Vicioso; E Muñoz; J C Carrasco
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.